Evidence map›Paper›PMID 33463026›Full record

ArticleEMBO reports2021

A multifaceted cellular damage repair and prevention pathway promotes high-level tolerance to β-lactam antibiotics.

Jung-Ho Shin, Donghui Choe, Brett Ransegnola, Hye-Rim Hong, Ikenna Onyekwere, Trevor Cross, Qiaojuan Shi, Byung-Kwan Cho, Lars F Westblade, Ilana L Brito and 1 more

Open access · greenAbstract read
In one paragraph

Article in EMBO reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Sporadic type VI secretion in seventh pandemicMicrobiology (Reading, England) · 2023
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Jung-Ho ShinWeill Institute for Cell and Molecular Biology, Cornell, University, Ithaca, NY, USA.ORCID 0000-0001-9411-1331
Donghui ChoeDepartment of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon, Korea.ORCID 0000-0003-1107-7380
Brett RansegnolaWeill Institute for Cell and Molecular Biology, Cornell, University, Ithaca, NY, USA.
Hye-Rim HongWeill Institute for Cell and Molecular Biology, Cornell, University, Ithaca, NY, USA.ORCID 0000-0002-8339-3190
Ikenna OnyekwereWeill Institute for Cell and Molecular Biology, Cornell, University, Ithaca, NY, USA.
Trevor CrossWeill Institute for Cell and Molecular Biology, Cornell, University, Ithaca, NY, USA.
Qiaojuan ShiMeinig School of Biomedical Engineering, Cornell University, Ithaca, NY, USA.ORCID 0000-0002-7588-2445
Byung-Kwan ChoDepartment of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon, Korea.ORCID 0000-0003-4788-4184
Lars F WestbladeDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
Ilana L BritoMeinig School of Biomedical Engineering, Cornell University, Ithaca, NY, USA.
Tobias DörrWeill Institute for Cell and Molecular Biology, Cornell, University, Ithaca, NY, USA.ORCID 0000-0003-3283-9161
Cornell University · USKorea Advanced Institute of Science and Technology · KR

Funding

Systems-Level Perspectives of Horizontal Gene Transfer Within the Human MicrobiomeDP2HL141007 · NHLBI · CORNELL UNIVERSITY · PI BRITO, ILANA LAUREN · 2017 to 2020
$2.6M
Cell envelope stress responses and the mechanism of antibiotic tolerance in Gram-negative pathogensR01AI143704 · NIAID · CORNELL UNIVERSITY · PI DOERR, TOBIAS · 2019 to 2023
$2.0M
The mechanism of autolysin regulation in Vibrio choleraeR01GM130971 · NIGMS · CORNELL UNIVERSITY · PI DOERR, TOBIAS · 2019 to 2025
$2.0M
NHLBI NIH HHS DP2 HL141007NIAID NIH HHS R01 AI143704NIGMS NIH HHS R01 GM130971NIH HHS 1DP2HL141007NIH HHS R01AI143704NIH HHS R01GM130971
6 · The paper itself

Abstract

Bactericidal antibiotics are powerful agents due to their ability to convert essential bacterial functions into lethal processes. However, many important bacterial pathogens are remarkably tolerant against bactericidal antibiotics due to inducible damage repair responses. The cell wall damage response two-component system VxrAB of the gastrointestinal pathogen Vibrio cholerae promotes high-level β-lactam tolerance and controls a gene network encoding highly diverse functions, including negative control over multiple iron uptake systems. How this system contributes to tolerance is poorly understood. Here, we show that β-lactam antibiotics cause an increase in intracellular free iron levels and collateral oxidative damage, which is exacerbated in the ∆vxrAB mutant. Mutating major iron uptake systems dramatically increases ∆vxrAB tolerance to β-lactams. We propose that VxrAB reduces antibiotic-induced toxic iron and concomitant metabolic perturbations by downregulating iron uptake transporters and show that iron sequestration enhances tolerance against β-lactam therapy in a mouse model of cholera infection. Our results suggest that a microorganism's ability to counteract diverse antibiotic-induced stresses promotes high-level antibiotic tolerance and highlights the complex secondary responses elicited by antibiotics.

Indexed as

beta-LactamsVibrio choleraeAnimalsAnti-Bacterial AgentsCell WallMiceAnti-Bacterial Agentsbeta-Lactamsantibiotic tolerancecell envelopestress responsetwo-component systemVibrio cholerae

Identifiers

PMID33463026
PMCPMC7857431
OpenAlexW3124241445

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.